ARAY - Accuray Incorporated

Accuray Incorporated designs, develops and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body in the Americas, Europe, the Middle East, India, Japan, Africa and the rest of the Asia Pacific region. The company is headquartered in Sunnyvale, California.

52W High

$2.95

52W Low

$1.14

MA Status:

50D: Above 200D: Below

Beta (~1 neutral, <0.9 lower risk)

1.27

Valuation

Rich

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

94.34

EV/EBITDA (<8 favorable)

14.29

EV/Revenue (<3 favorable)

0.63

P/S (TTM) (<3 favorable)

0.37

P/B (<3 favorable)

2.10

Ownership

Balanced

Source: Overview

Insiders (1–5% typical)

2.06%

Institutions (25–75% balanced)

71.33%

Shares Outstanding

112,677,000

Float

108,972,000

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

458,505,000

Gross Profit (TTM)

146,967,000

EPS (TTM)

-0.02

Profit Margin (>10% good)

0.00%

Operating Margin (TTM) (higher better)

0.04%

ROE (TTM) (>15% strong)

-0.03%

EPS YoY (Quarterly) (>10% good)

-0.96

Revenue YoY (Quarterly) (>8% good)

0.17

Momentum

Bearish momentum

Value

0.0428

0.0434

Trend

Falling

Signal Cross

No cross

As of

Sep. 12, 2025